Ledger.Open graph →
SEC Form D · filed May 14, 2019

Reneo Pharmaceuticals, Inc

Offering
$25.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Diego, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Ed Mathers · San Diego, CADirectorMichael Grey · San Diego, CADirectorAlejandro Dorenbaum, M.D · San Diego, CAExecNiall O'Donnell, Ph.D · San Diego, CAExec · DirectorWendy Johnson · San Diego, CAExecLon Cardon, Ph.D · San Diego, CADirectorJohan Kordel, Ph.D · San Diego, CADirectorArt Pappas · Mill Valley, CADirectorMarco Strub · VANCOUVER, British Columbia, CanadaExecElizabeth Mendoza · Tieton, WAExec · DirectorBrian Bower · VANCOUVER, British Columbia, CanadaExecRosalinda Mendoza · Tieton, WADirectorJohn Anderson · VANCOUVER, British Columbia, CanadaDirectorJonathan Gazdak · New York, NYDirectorRakesh Patel · VANCOUVER, British Columbia, CanadaDirectorDorrell P. Hinshaw · Solana Beach, CADirectorJean P. Balgrosky · Solana Beach, CAExec · DirectorSamir P. Damani · Solana Beach, CADirectorKyle P. Williams · Solana Beach, CADirectorDavid M. Stott · CHICAGO, ILDirectorChad S. Alfeld · SIMSBURY, CTExecTina E. St. Pierre · SIMSBURY, CTExecArt Pappas · Mill Valley, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗